Trial intelligence / Profile preview

FCM vs IS for Iron Deficiency Anemia in Pregnant Women

NCT07721519Not yet recruiting

Sponsor
Hawler Medical University
Start
Sep 2026
Primary completion
Mar 2028
01

Overview

Randomised, single-blind trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Hawler Medical University. Primary endpoint: Change from Baseline in Hemoglobin (Hb) Levels. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT07721519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07721519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call